Shareholder advocacy

May 2024 Dialogue with AES on climate change; covered greenhouse gas targets and climate-related disclosures, climate lobbying, energy efficiency, Just Transition, and renewable energy and capital expenditure plans.
Aug. 2023 Dialogue with AEP on greenhouse gas targets and climate-related disclosures, climate lobbying, energy efficiency, Just Transition, renewable energy and capital expenditure plans.

April 2024 Climate change dialogue with Duke on Just Transition, Scope 3 emissions (the result of activities from assets not owned or controlled by the reporting organization, but that the organization indirectly affects in its value chain), capital alignment, decarbonization strategy, and policy alignment.

May 2024 Dialogue with Southern on climate, covering the company’s new nuclear unit, long term emissions-reduction plans, and an update on Just Transition.

March 2023 Dialogue on climate change including CapEx alignment versus climate scenarios, end use of products (Scope 3 emissions), climate lobbying and trade associations, and board oversight of climate strategy.

April 2024 Dialogue with BAC centering on coal financing and Arctic drilling and how the company’s climate commitments line up with its lending portfolio.

Sept. 2023 Dialogue on climate change, covering Net Zero carbon commitments, greening the company’s lending portfolio, and renewable energy financing.

Sept. 2023 Dialogue on climate change, covering Net Zero carbon commitments, greening the company’s lending portfolio, and renewable energy financing.

Aug. 2023 Joined investor letter encouraging ISS to strengthen its benchmark policy on climate, as well as develop specialty policies that would provide a gold-standard approach to comprehensive climate voting recommendations and issuer analysis.

May 2024 Joined the most recent iteration of the Global Investor Statement to Governments on the Climate Crisis to keep pressure on policymakers to move toward a low carbon economy.

June 2024 Joined investor statement on plastics calling on petrochemical companies that produce plastic polymers to take stronger actions towards plastics circularity. Plastic pollution – including uptake into our bodies – has become a major issue and creating a circular plastic life cycle could help to address the problem.

June 2024 Participated in investor statement to encourage global policymakers to take action ahead of a United Nations meeting on Antimicrobial Resistance (AMR) in September. The statement outlines seven key asks and provides an opportunity for investors to highlight their concerns regarding the threat of AMR as a systemic risk to investment portfolios, economic stability, and broader society.

Jan. 2023 Dialogue with McDonald’s on ground for withdrawal of our shareholder proposal. The proposal requests that the company adopt an enterprise-wide policy to phase out the use of medically important antibiotics in its beef and pork supply chains.

March 2023 Dialogue with BRF on biodiversity, waste, and pollution risks and opportunities in its agricultural practices.

July 2023 Dialogue to discuss the company’s ongoing efforts to address human trafficking, including employee training, victims’ services, and coordination with law enforcement.

April 2024 Dialogue with Apple on what the company is doing to prevent online child exploitation and collaborate with industry peers and government authorities. The dialogue was one of the outcomes of shareholders withdrawing their proposal on the subject.
Sept. 2023 Co-filed shareholder proposal requesting that Apple publish a report by March 2025 that assesses the risks of its products and services being used to facilitate online sexual exploitation of children, and the company’s efforts to prevent this activity.
Feb. 2023 Joined investor letter to Apple requesting that they improve their response to child safety risks and asking for a dialogue on the subject.

Feb. 2023 Dialogue with AT&T on prevention and action regarding online child exploitation. Conversation focused on measures companies are taking to protect children, metrics companies can report on this subject, and partnerships with law enforcement, NGOs, and industry peers.

Sept. 2023 Dialogue on their mining operations and relations with workers and indigenous tribes.

March 2023 Dialogue on indigenous rights with ConocoPhillips focusing on indigenous communities in Alaska’s North Slope, the Willow Project, and the process for gaining consent for development from communities.
Aug. 2022 Joined letter from the Gwich'in Steering Committee to leading insurance companies asking them not to insure drilling efforts in the Arctic Refuge to respect the rights of Alaska Indigenous communities, and avoid harming wildlife and exacerbating climate change.

Sept. 2023 Joined investor letter asking the company to pay outstanding wage payments for garment workers in factories in Cambodia and Thailand employed by the Ramatex Group. Workers were dismissed and/or did not receive legally owed partial wages during a factory shutdown.

April 2024 Joined investor letter to the six largest chocolate companies, urging them to help facilitate living wage income for farmers to reduce dependence on child labor.

April 2024 Joined multi-stakeholder letter to the EU Parliament calling on lawmakers to adopt the EU’s regulation to prohibit forced labor products in the EU marketplace.

Sept. 2023 Signed on to investor letter requesting a meeting to discuss how the company is implementing the worker health and safety audit shareholder proposal and to share investor recommendations for the audit and reporting process.

April 2024 Dialogue with Dollar General on living wages, including discussion about living wage policy adoption, cost-benefit analyses of wage increases, and wage-setting strategies and compensation metrics.

Feb. 2023 Joined investor statement regarding the European Commission’s proposed legislation governing artificial intelligence (AI). While AI can enable advancements in some areas, it can contribute towards harms such as wide-spread surveillance, invasion of privacy and discrimination against the most vulnerable.

Jan. 2023 Signed on to investor statement supporting robust forced labor regulations and welcoming the European Commission’s proposal to prohibit products made with forced labor from entering the European Union market.

March 2023 Joined investor statement in support of ending the subminimum wage;. A “subminimum wage” is a wage paid that is less than the federal or state mandated minimum wage, which federal law allows with certain groups of workers. The subminimum wage upholds systemic racism and disproportionately impacts women.

June 2024 Joined investor petition calling on the SEC to draft a rule to require US-listed issuers to provide additional disclosure of basic tax and relevant financial and operational information disaggregated by country; we believe that tax transparency can mitigate regulatory risks and provide more fairness regarding the tax burden.

Feb. 2023 Joined investor letter requesting a dialogue on the company's future strategy on tobacco sales and statements promising transparency regarding the issue.

Feb. 2023 Participated in investor letter to Congress in support of the Department of Labor’s ESG Rule and opposing actions that would take away investor choice.

Aug. 2023 Pharmaceutical companies are filing a lawsuit against the Department of Health and Human Services over the IRA provision allowing the government to negotiate drug prices. Joined investor statement asking the companies and their trade associations to drop the lawsuits.